Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.4.0.3
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Mar. 31, 2014
Revenue $ 88,203 $ 84,127 $ 102,073
Cost of revenue 53,687 57,317 61,612
Gross profit 34,516 26,810 40,461
Operating expenses:      
Research and development 19,317 17,348 11,339
Sales and marketing 15,817 12,407 13,304
General and administrative 9,836 14,678 14,027
Intangible amortization 5,554 6,377 4,889
Restructuring 748 3,243 335
Goodwill impairment 0 31,997 0
Total operating expenses 51,272 86,050 43,894
Operating income (loss) from continuing operations (16,756) (59,240) (3,433)
Other income (expense), net 169 (2) (56)
Income (loss) before income taxes and discontinued operations (16,587) (59,242) (3,489)
Income tax (expense) benefit 102 201 7,910
Net income (loss) from continuing operations (16,485) (59,041) 4,421
Discontinued operations (Note 1):      
Income (loss) from discontinued operations, net of tax benefit (expense) of $(171), $(88) and $0 for fiscal years 2016, 2015 and 2014, respectively 273 139 (45)
Net income (loss) $ (16,212) $ (58,902) $ 4,376
Basic net income (loss) per share:      
Basic net income (loss) from continuing operations $ (0.27) $ (0.98) $ 0.08
Basic net income (loss) from discontinued operations 0.00 0.00 0.00
Basic net income (loss) per share (0.27) (0.98) 0.07 [1]
Diluted net income (loss) per share:      
Diluted net income (loss) from continuing operations (0.27) (0.98) 0.07
Diluted net income (loss) from discontinued operations 0.00 0.00 0.00
Diluted net income (loss) per share $ (0.27) $ (0.98) $ 0.07
Weighted-average number of Common shares outstanding:      
Basic 60,786 59,985 58,786
Effect of dilutive securities: restricted stock, restricted stock units, performance stock units and stock options(2) [2] 0 0 1,262
Diluted 60,786 59,985 60,048
[1] Sums may not total due to rounding.
[2] The Company has 3.7 million and 3.3 million shares represented by common stock equivalents for the twelve months ended March 31, 2016 and 2015, respectively, which were not included in the computation of average dilutive shares outstanding because they were anti-dilutive. In periods with a net loss from continuing operations, the basic loss per share equals the diluted loss per share as all common stock equivalents are excluded from the per share calculation because they are anti-dilutive. The Company had 0.6 million common stock equivalents represented by options for the twelve months ended March 31, 2014, which were not included in the computation of average dilutive shares outstanding because they were anti-dilutive.